Christopher Jackson
Cited by
Cited by
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas
J Zeng, AP See, J Phallen, CM Jackson, Z Belcaid, J Ruzevick, N Durham, ...
International Journal of Radiation Oncology* Biology* Physics 86 (2), 343-349, 2013
Combination therapy with anti-PD-1, anti-TIM-3, and focal radiation results in regression of murine gliomas
JE Kim, MA Patel, A Mangraviti, ES Kim, D Theodros, E Velarde, A Liu, ...
Clinical Cancer Research 23 (1), 124-136, 2017
Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model
Z Belcaid, JA Phallen, J Zeng, AP See, D Mathios, C Gottschalk, ...
PloS one 9 (7), e101764, 2014
Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
D Mathios, JE Kim, A Mangraviti, J Phallen, CK Park, CM Jackson, ...
Science translational medicine 8 (370), 370ra180-370ra180, 2016
Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment
C Jackson, J Ruzevick, J Phallen, Z Belcaid, M Lim
Clinical and Developmental Immunology 2011, 2011
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
AL Hung, R Maxwell, D Theodros, Z Belcaid, D Mathios, AS Luksik, E Kim, ...
Oncoimmunology 7 (8), e1466769, 2018
STAT3 activation in glioblastoma: biochemical and therapeutic implications
JE Kim, M Patel, J Ruzevick, CM Jackson, M Lim
Cancers 6 (1), 376-395, 2014
Lymphocyte Activation Gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo
NM Durham, CJ Nirschl, CM Jackson, J Elias, CM Kochel, RA Anders, ...
PloS one 9 (11), e109080, 2014
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
S Wada, CM Jackson, K Yoshimura, HR Yen, D Getnet, TJ Harris, ...
Journal of translational medicine 11 (1), 89, 2013
Immunotherapy for brain cancer: recent progress and future promise
CM Jackson, M Lim, CG Drake
Clinical Cancer Research 20 (14), 3651-3659, 2014
Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors
KL Chaichana, C Pendleton, C Jackson, JC Martinez-Gutierrez, ...
Neurological research 35 (2), 206-211, 2013
Clinical trials investigating immune checkpoint blockade in glioblastoma
R Maxwell, CM Jackson, M Lim
Current treatment options in oncology 18 (8), 51, 2017
Mechanisms of immunotherapy resistance: lessons from glioblastoma
CM Jackson, J Choi, M Lim
Nature immunology 20 (9), 1100-1109, 2019
The role of STAT3 activation in modulating the immune microenvironment of GBM
AP See, JE Han, J Phallen, Z Binder, G Gallia, F Pan, D Jinasena, ...
Journal of neuro-oncology 110 (3), 359-368, 2012
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
MA Patel, JE Kim, D Theodros, A Tam, E Velarde, CM Kochel, B Francica, ...
Journal for immunotherapy of cancer 4 (1), 1-13, 2016
Systemic tolerance mediated by melanoma brain tumors is reversible by radiotherapy and vaccination
CM Jackson, CM Kochel, CJ Nirschl, NM Durham, J Ruzevick, A Alme, ...
Clinical Cancer Research 22 (5), 1161-1172, 2016
Vaccine strategies for glioblastoma: progress and future directions
C Jackson, J Ruzevick, H Brem, M Lim
Immunotherapy 5 (2), 155-167, 2013
PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
D Mathios, J Ruzevick, CM Jackson, H Xu, S Shah, JM Taube, PC Burger, ...
Journal of neuro-oncology 121 (2), 251-259, 2015
Potential role for STAT3 inhibitors in glioblastoma
C Jackson, J Ruzevick, AG Amin, M Lim
Neurosurgery Clinics 23 (3), 379-389, 2012
Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma
T Garzon-Muvdi, D Theodros, AS Luksik, R Maxwell, E Kim, CM Jackson, ...
Oncotarget 9 (29), 20681, 2018
The system can't perform the operation now. Try again later.
Articles 1–20